ACRYLATE-AMIDE FOAM CARDIOVASCULAR PROSTHESES.
Final rept., 1 Jan 60-1 July 62,
BAYLOR UNIV HOUSTON TEX COLL OF MEDICINE
Pagination or Media Count:
An evaluation of an open cell, foam acrylateamide prosthetic material is presented. The preliminary work with this material was in the development of a new arterial prosthesis, a composite graft of woven dacron reinforced acrylateamide foam. The arterial prosthesis is easily handled and the foam construction increases biological permeability while reducing the physical permeability, thus permitting rapid intimization without excessive bleeding. The success of the initial experimental work has led to a clinical trial in which 99 replacement, bypass, or patch-angioplasty procedures have been performed for disease of the carotid, vertebral, subclavian, renal, iliac, femoral, popliteal, and posterior tibial arteries as well as the thoracic and abdominal aorta. The use of a composite construction utilizing acrylate-amide foam is being evaluated in prostheses for mitral valve replacement, superior vena cava patch venoplasty, and esophageal replacement. Author